News

Under the agreement, Osteotech has the exclusive right to distribute the Bone Marrow Aspirate Concentrate (BMAC) System for bone regeneration in orthopedic and spinal surgical procedures in most

Cypress will also get an additional $37.5 million in potential milestone-related payments associated with the development of Proprius’s therapeutic candidates. The acquisition brings together Cypress’s drug development expertise,

The first study examined the effects of linaclotide in patients with chronic constipation (CC), while the second study examined its effects in patients with irritable bowel syndrome with

Oracle Healthcare and Precision determined that, due to currently prevailing market conditions, terminating the merger agreement was in the best interests of both the companies, as well as

This unprecedented step was the result of a recent publication that examined all available data on the antidepressants, including trials that had not been published. The study found

The department of health (DoH) has informed the Association of the British Pharmaceutical Industry that it is giving six months’s notice to end the PPRS, as it is

According to Arthur Higgins, chairman of Bayer Healthcare, the company has no plans to divest its consumer health division that has registered a 6.95% rise in sales in

The recommendation is based on the results of an interim review of the study being undertaken by Hunter-Fleming. The Phase IIa multi-centre, double blind placebo controlled, biomarker trial

This first in human study aims to evaluate the safety and tolerability of FIXFc together with its pharmacokinetic profile (primarily its plasma half-life) after a single injection of